Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022
Source
Eurosurveillance : European communicable disease bulletin - ISSN 1560-7917-30:10 (2025) p. 1-18
COVID-19 and SARS-CoV-2 vaccination related T-cell immune response in diverse populations
Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2025,173 p.
Genomic epidemiological analysis of a single-centre polyclonal outbreak of Serratia marcescens, Belgium, 2022 to 2023
Source
Eurosurveillance : European communicable disease bulletin - ISSN 1025-496X-29:48 (2024) p. 1-10
Interleukin‐2‐mediated CD4 T‐cell activation correlates highly with effective serological and T‐cell responses to SARS‐CoV‐2 vaccination in people living with HIV
Source
Journal of medical virology - ISSN 0146-6615-96:8 (2024) p. 1-14
Immunological biomarkers of COVID-19 : response to vaccination and monoclonal antibody treatments in immunocompromised patients
Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2023,193 p.